REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Cancerologico De Narino S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Cancerologico De Narino S.A.S. Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Instituto Cancerologico De Narino S.A.S. is a company based in Colombia, with its head office in Pasto. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on November 20, 2001. From the latest financial highlights, Instituto Cancerologico De Narino S.A.S. reported a net sales revenue increase of 23.4% in 2025. Its’ total assets recorded a growth of 37.09%. The net profit margin of Instituto Cancerologico De Narino S.A.S. decreased by 0.2% in 2025.

Headquarters
Carrera 40A Nro. 19B - 55 Av. Panamericana
Pasto; Narino;

Contact Details: Purchase the Instituto Cancerologico De Narino S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Instituto Cancerologico De Narino S.A.S. report to view the information.
Financial Auditors:
Purchase the Instituto Cancerologico De Narino S.A.S. report to view the information.
Incorporation Date:
November 20, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Cancerologico De Narino S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
23.4%
Total Operating Revenue
23.4%
Operating Profit
21.97%
EBITDA
23.56%
Net Profit/Loss for the Period
21.4%
Total Assets
37.09%
Total Equity
8.03%
Operating Profit Margin
-0.25%
Net Profit Margin
-0.2%
Return on Equity (ROE)
1.4%
Debt / Equity
29.38%
Quick Ratio
-2.21%
Cash Ratio
-0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?